Company Filing History:
Years Active: 2023-2024
Title: Gustavo Fenalti: Innovator in Protein Modulation
Introduction
Gustavo Fenalti is a prominent inventor based in San Diego, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of protein modulation. With a total of 2 patents, Fenalti's work focuses on innovative methods that enhance our understanding of cellular signaling.
Latest Patents
Fenalti's latest patents include compositions and methods involving antibodies that specifically bind to signal regulatory protein-α (SIRPα). These inventions aim to modulate the activity of SIRPα, providing new avenues for therapeutic applications. His patents are titled "SIRP-α binding proteins and methods of use thereof," which detail the compositions and uses of these antibodies.
Career Highlights
Gustavo Fenalti is currently associated with Celgene Corporation, where he continues to advance research in protein interactions and their implications in disease treatment. His work has been instrumental in developing new therapeutic strategies that leverage the modulation of SIRPα.
Collaborations
Fenalti collaborates with notable colleagues, including Mahan Abbasian and Henry Chan. Their combined expertise fosters a dynamic research environment that drives innovation in their field.
Conclusion
Gustavo Fenalti's contributions to biotechnology through his patents and collaborative efforts highlight his role as a key innovator in protein modulation. His work continues to pave the way for advancements in therapeutic applications.